Implant Sciences' QS-B220 receives regulatory approval for China airports and civil aviation industry

WILMINGTON, Mass. - Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced its QS-B220 desktop explosives and drugs trace detector has received approval from the Civil Aviation Administration of China (CAAC).

"We are proud to have received approval for the QS-B220 from CAAC, which is the equivalent of the TSA in the United States. China has traditionally been a very strong market for us, with hundreds of our trace detection systems being currently used by police, airports, and subways. We believe our reputation for quality and performance will translate into significant QS-B220 sales in the Chinese market," stated Implant Sciences' CEO, Glenn D. Bolduc. "The QS-B220 is the only trace ETD in the world to currently have passed testing by the TSA in the United States, ECAC in Europe, and CAAC in China."

146 airports in China recently received $196 million in subsidies from the Civil Aviation Administration of China earlier in December 2014. According to the Chinese government's 12th five-year plan, the total number of airports is set to expand from 175 in 2010 to 230 in 2015.

sourced:traveldailynews.asia